• OPEN AN ACCOUNT
Indian Indices
Sensex
78,305.59 -333.44
( -0.42%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

RPG Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532983
INE105J01010
366.0261581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RPGLIFE
39.13
4564.85
EPS(TTM)
Face Value()
Div & Yield %
70.54
8
0.87
 

Coral Laboratories standalone net profit rises 84.45% in the March 2026 quarter
Jun 01,2026
Net profit of Coral Laboratories rose 84.45% to Rs 5.22 crore in the quarter ended March 2026 as against Rs 2.83 crore during the previous quarter ended March 2025. Sales declined 5.87% to Rs 26.48 crore in the quarter ended March 2026 as against Rs 28.13 crore during the previous quarter ended March 2025.

For the full year,net profit declined 32.20% to Rs 16.38 crore in the year ended March 2026 as against Rs 24.16 crore during the previous year ended March 2025. Sales declined 25.31% to Rs 85.90 crore in the year ended March 2026 as against Rs 115.01 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.4828.13 -6 85.90115.01 -25
OPM %23.389.56 -17.7122.82 -
PBDT8.835.13 72 24.9435.25 -29
PBT8.294.62 79 22.8033.24 -31
NP5.222.83 84 16.3824.16 -32